Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sandu Pharmaceuticals Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sandu Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sandu Pharmaceut - Announcement Under Regulation 30-Response To Discrepancy Related To Delay In Submission Of Information Reg

    4 Jun 2025, 4:16PM Response for delay submission of the show cause notice received from Maharashtra GST
  • Sandu Pharmaceut - Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of The 'Promoter Grou

    30 May 2025, 3:20PM intimation of submission of application to Bombay Stock Exchange (BSE) for reclassification from Promoter Group category to Public category
  • Sandu Pharmaceut Q4 net profit down 44.07% at Rs 0.33 cr

    29 May 2025, 2:33PM The company reported standalone net profit of Rs 0.33 crore for the quarter ended March 31, 2025 as compared to Rs 0.59 crore in the same period last
  • Sandu Pharmaceut - Announcement Under Regulation 30

    28 May 2025, 10:00PM Announcement under Regulation 30
  • Sandu Pharmaceut - Announcement under Regulation 30 (LODR)-Dividend Updates

    28 May 2025, 9:50PM Board considers Final Dividend for the FY 2024-25
  • Sandu Pharmaceut - Announcement under Regulation 30 (LODR)-Change in Management

    28 May 2025, 9:47PM Appointment of Secretarial Auditor and Reappointment of Cost Auditor
  • Sandu Pharmaceut - Corporate Action-Board approves Dividend

    28 May 2025, 9:41PM Board Approves Final dividend for the FY 2024-25.
  • Sandu Pharmaceut - Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations\r\nAnd Disclosure

    28 May 2025, 9:39PM Approval of Board for reclassification of Akshath Finvest and Properties Private Limited ,Promoter Group Category into Public Category under Reg 31A o
  • Sandu Pharmaceut - Audited Standalone And Consolidated Financial Results For The Q And Year Ended 31.03.2025

    28 May 2025, 9:33PM Audited Standalone and consolidated Financial Results for Q and Year Ended 31.03.2025
  • Sandu Pharmaceut - Board Meeting Outcome for Outcome Of The Board Meeting Dated 28Th May 2025

    28 May 2025, 9:24PM Outcome of the Board Meeting
  • Sandu Pharmaceut - Announcement Under Regulation 30 Receipt Of Request For Reclassification From 'Promoter And Promoter Grou

    24 May 2025, 1:19PM Receipt of the Request from Akshath finvest and Properties Private Limited (Promoter Group) for Reclassification from Promoter category into Public
  • Sandu Pharmaceut - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    21 Apr 2025, 11:21AM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Sandu Pharmaceut - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    21 Apr 2025, 10:59AM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Sandu Pharmaceut - Announcement Under Regulation 30(LODR)-Update-Intimation For Change In The Email Address And Website Addre

    18 Apr 2025, 1:29PM Change of email address and Website address of MUFG intime India Private Limited
  • Sandu Pharmaceut has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    17 Apr 2025, 11:50AM As of March 2025, 42.91% is owned by Indian Promoters and 57.10% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Sandu Pharmaceut - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    5 Apr 2025, 2:53PM Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018
  • Sandu Pharmaceut - Disclosure In Terms Of Regulation 31(4) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regul

    3 Apr 2025, 4:59PM Disclosure in term of regulation 31(4) of the SEBI (SAST) Regulation 2011

Key fundamentals

Evaluate the intrinsic value of Sandu Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 42.0754 40.5953 39.2444 36.4746 33.5104
Liabilities 42.0754 40.5953 39.2444 36.4746 33.5104
Equity 9.661 9.661 9.661 8.8107 7.9209
Gross Profit 2.7622 2.2973 2.4893 2.874 2.159
Net Profit 1.5489 1.4606 1.5239 1.5893 1.0924
Cash From Operating Activities 0.9504 0.7614 0.2212 0.9487 7.59
NPM(%) 2.3 2.17 2.33 2.42 1.85
Revenue 67.1924 67.2807 65.349 65.5005 58.7554
Expenses 64.4302 64.9834 62.8597 62.6265 56.5963
ROE(%) 3.79 3.57 3.73 3.89 2.67

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sandu Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 859.90 1.12 28.38 29.84 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.27 -2.54 205.89 108.74 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 26.00 1.13 0.00 225.79 -39.50 0.00
Astec Lifesciences Ltd 806.15 -0.38 0.00 102.54 -687.10 0.00

Company Info

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.

Read More

Parent Organisation

Sandu Pharmaceuticals Ltd.

Founded

15/11/1985

Managing Director

NSE Symbol

FAQ

The current price of Sandu Pharmaceuticals Ltd is

The 52-week high for Sandu Pharmaceuticals Ltd is

The market capitalization of Sandu Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sandu Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sandu Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sandu Pharmaceuticals Ltd shares.

The CEO of Sandu Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT